[pending] BUPROPION HYDROCHLORIDE (BUPROPION HYDROCHLORIDE)
Pending LLM rewrite. Source: FDA_DRUG D-0037-2026.
- Product
- BUPROPION HYDROCHLORIDE — BUPROPION HYDROCHLORIDE (BUPROPION HYDROCHLORIDE)
- Category
- Drug
- Distribution
- Distributed nationwide
State
19,787 recalls have nationwide distribution and so reach Iowa. 0 additional recalls listed Iowa specifically in their distribution scope.
Most US product recalls have nationwide distribution — the manufacturer ships into every state and the recall sweeps the same way. We include those in this listing because they affect Iowa consumers even though the source notice doesn’t name the state. State-specific recalls are usually for products with regional distribution (a regional dairy, a local store brand) or where the agency was able to narrow the affected shipments to specific destinations.
If you’re checking whether a recall affects your purchase, the recall detail page lists the exact production lot codes, UPCs, and best-by dates. Match those against your package — distribution scope is a starting filter, not the final answer.
Pending LLM rewrite. Source: FDA_DRUG D-0037-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0239-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0231-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0237-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0215-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0149-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0032-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0030-2026.
Pending LLM rewrite. Source: CPSC 26040.
Pending LLM rewrite. Source: CPSC 26046.
Pending LLM rewrite. Source: CPSC 26050.
Pending LLM rewrite. Source: CPSC 26038.
Pending LLM rewrite. Source: CPSC 26047.
Pending LLM rewrite. Source: CPSC 26037.
Pending LLM rewrite. Source: CPSC 26044.
Pending LLM rewrite. Source: CPSC 26048.
Pending LLM rewrite. Source: CPSC 26036.
Pending LLM rewrite. Source: CPSC 26049.
Pending LLM rewrite. Source: FDA_DEVICE Z-0155-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0029-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0133-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0189-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0144-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0018-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0137-2026.